HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kondo, D. G. Articles by Steffens, D. C. Search for Related Content PubMed PubMed Citation Articles by Kondo, D. G. Articles by Steffens, D. C.

Association of AGTR1 With 18-Month Treatment Outcome in Late-Life Depression

From the Department of Psychiatry and Behavioral Sciences (DGK, KRK, DRM, CFP, DCS) and the Center for Human Genetics (MCS, SHS, AVB), Duke University Medical Center, Durham, NC.

Objective: Converging lines of evidence implicate vascular factors in late-life depression, and argue that late-life depression is a distinct entity among the mood disorders. The A1166C polymorphism in the angiotensin II receptor, vascular type 1 (AGTR1) gene has been associated with a range of vascular diseases. This study investigated the association of AGTR1 genotype on 18-month treatment outcome in late-life depression.

Methods: In a large, prospective cohort study, patients with late-life depression received individualized treatment using a standardized algorithm. The authors genotyped participants at the AGTR1 A1166C single nucleotide polymorphism (SNP) using standardized methodology, then used survival analysis to estimate the impact of A1166C and demographic variables on time to remission during 18 months of follow-up.

Results: The hazard ratio for AGTR1 homozygous C/C status was 0.37. The A1166C SNP showed evidence for genotypic and allelic association in a comparison of remitted and unremitted/censored subjects.

Conclusion: Consistent with its association with numerous vascular disorders, AGTR1 is associated with treatment outcome in late-life depression. Further studies are needed to replicate this finding, and to investigate the impact of other genetic markers of vascular disease on late-life depression outcome.

Key Words: Geriatric depression • genetics • AGTR1 • treatment outcome • cohort studies

This article has been cited by other articles:

				B. S. Meyers Optimizing the Use of Data Generated by Geriatric Depression Treatment Studies During a Time of Diminishing Resources Am J Geriatr Psychiatry, July 1, 2007; 15(7): 545 - 552. [Full Text] [PDF]